ST Segment Detection Study
Public ClinicalTrials.gov record NCT00930969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of ST Detect study is to evaluate whether naturally occurring spontaneous coronary events and exercise induced cardiac ischemia, give rise to detectable changes on intracardiac electrogram (EGM) signals in patients that are indicated for an Implantable Cardioverter Defibrillator (ICD) who have coronary artery disease.
Study identification
- NCT ID
- NCT00930969
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 175 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2008 (Type not available)
- Primary completion
- Nov 2010 (Actual)
- Completion
- Mar 2011 (Actual)
- Last update posted
- Feb 18, 2019
2008 – 2011
United States locations
- U.S. sites
- 17
- U.S. states
- 14
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anchorage | Alaska | 99508 | — |
| Not listed | Brandon | Florida | 33511 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Davenport | Iowa | 52803 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Minneapolis | Minnesota | 55407 | — |
| Not listed | Kansas City | Missouri | 64111 | — |
| Not listed | Mineola | New York | 11501 | — |
| Not listed | Stony Brook | New York | 11794 | — |
| Not listed | Gastonia | North Carolina | 28054 | — |
| Not listed | Raleigh | North Carolina | 27610 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Burlington | Vermont | 05401 | — |
| Not listed | Richmond | Virginia | 23225 | — |
| Not listed | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00930969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 18, 2019 · Synced Nov 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00930969 live on ClinicalTrials.gov.